<DOC>
	<DOCNO>NCT02443584</DOCNO>
	<brief_summary>This randomize , control group design pharmacogenetic implementation mental health population subject take anti-depressants and/or anti-psychotics new current primary secondary diagnosis Major Depressive Disorder ( MDD ) Depressive Disorder Not Otherwise Specified ( DDNOS ) .</brief_summary>
	<brief_title>Pharmacogenetic Testing Outpatient Population With Depression Diagnosis</brief_title>
	<detailed_description>Mental illness affect one four adult United States ; approximately 61.5 million Americans experience mental illness give year . According National Alliance Mentally Ill , impact serious mental illness cost Americans $ 193.2 billion lose earnings per year . In addition , mental illness patient increase risk chronic medical condition , lead increased cost emergency service utilization condition . In addition substantial cost , patient psychiatric illness difficult treat . More two-thirds patient depression respond first line therapy . Treatment often involve numerous trial individual agent combination medication order achieve optimal response . Pharmacogenetic testing use setting guide treatment decision .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Current primary secondary diagnosis Major Depressive Disorder Depressive Disorder Not Otherwise Specified Have moderate severe depression identify PHQ9 score 10 great Taking newly prescribe antidepressant antipsychotic medication Able provide inform consent Pregnant breastfeed Active and/or unstable diagnosis substance abuse , exclude nicotine Primary diagnosis dementia , bipolar disorder ( type ) , schizophrenia , schioaffective disorder , personality disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>depression</keyword>
	<keyword>pharmacogenetics</keyword>
	<keyword>pharmacogenomics</keyword>
	<keyword>major depressive disorder</keyword>
	<keyword>genetics</keyword>
	<keyword>anti-depressants</keyword>
</DOC>